Abstract: Each diastereomer of 10-thiophenyl-and 10-benzenesulfonyl-dihydroartemisinin was synthesized from artemisinin in three steps, and screened against chloroquine-resistance and chloroquine-sensitive Plasmodium falciparum. Three of the four tested compounds were found to be effective. Especially, 10β-benzenesulfonyl-dihydroartemisinin showed stronger antimalarial activity than artemisinin.
The natural sesquiterpene endoperoxide artemisinin ( Fig. 1-1) , which was isolated from Artemisia annua L. (Klayman, 1985) , has become a potential lead compound in the development of an antimalarial (Luo and Shen, 1987; Jung, 1994; Haynes and Vonwiller, 1997; Vroman et al., 1999) and recently anticancer agents (Beekman et al., 1997; Jung et al., 2003; Posner et al., 2003) . The semi-synthetic, acetal-type, artemisinin derivatives ( Fig. 1-3 ), ether and ester derivatives of trioxane lactol dihydroartemisinin ( Fig.  1-2) , were developed for their higher antimalarial efficacy and are now widely used to treat malarial patients ( Fig. 1) (Brossi et al., 1988) .
Although these acetal artemisinin derivatives showing potent antimalarial activity in vitro, the acetal functional group at the C-10 position is responsible for chemical instability (Jung and Lee, 1998) , and toxicity (Gordi and Lepist, 2004) . Therefore, to improve bioavailability, it is important to discover novel artemisinin derivatives suitable to chemo-antimalarial therapy. In 1995, Venugopalan et al. reported a series of thioacetal type artemisinin derivatives, some of which have potent antimalarial activity in vivo.
In 1998, Posner et al. also reported that sulfide and sulfone endoperoxide from R-(+)-limonene (Bachi et al., 1998) and sulfone trioxanes Posner et al., 2000) have similar or less activity to natural artemisinin. However, because there is no report on C-10 sulfonyl artemisinin derivatives (Fig. 2) , we decided to investigate and report the synthesis and antimalarial activity of such derivatives. , Jae-Sook RYU 5) and Han-Kyu CHOI 5)
TESTED COMPOUNDS
As seen in Fig. 3 , separable diastereomeric mixtures of 10α-( Fig. 3-5 ) and 10β-thiophenyl-dihydroartemisinins were prepared by reacting known dihydroartemisinin ( Fig. 1-2 ) (Lin et al., 1987) with thiophenol (2eq) under the catalysis of BF 3 Et 2 O (1eq) at room temperature for 10 minutes (Venugopalan et al., 1995; Oh et al., 2004a Oh et al., , 2004b . The thioacetal products were transformed to produce 10α-( Fig. 3-7 ) and 10β-benzenesulfonyl-dihydroartemisinins ( Fig. 3-8 ), respectively, in good yields, by performing oxidation with H 2 O 2 /urea complex (UHP), trifluoroacetic anhydride (TFAA) and NaHCO 3 (Varma and Naicker, 1999; Caron et al., 2000) .
Strains of Plasmodium falciparum
Two culture-adapted strains of P. falciparum were used: the chloroquine-sensitive strain FCR-8/West African, and chloroquine-resistant strain FCR-3/Gambia subline F-86 of P. falciparum obtained from ATCC (Nguyen-Dinh and Trager, 1980; Jensen and Trager, 1978) . The medium used was RPMI medium containing hypoxanthine and supplemented with HEPES buffer, sodium bicarbonate, human A serum, glutamine, gentamicin, and uninfected human O erythrocytes.
In vitro measurement of parasite growth inhibition by drugs
The assays were conducted in vitro by a modification of the semiautomated microdilution technique of Desjardins et al. (1979) and Delhaes et al. (2002) sitemia with a majority of ring stages, 1.8-2% haematocrit) and [H 3 ]hypoxanthine (Amersham, UK, TRK74, 1µl per well), the test plates were incubated at 37°C for 24 h in an atmosphere of 5% O 2 , 5% CO 2 , and 90% N 2 . Growth of the parasites was estimated from the incorporation of radiolabeled [H 3 ]hypoxanthine into the parasites` nucleic acids, measured in a liquid scintillation spectrometer (Packard, USA). The 50% inhibitory concentration (IC50) values refer to the molar concentrations of drug causing a 50% reduction in [H 3 ]hypoxanthine incorporation, compared to drug-free control wells. IC50 values were estimated by linear regression analysis of log-dose-response curves.
In the screening of the two standard molecules, chloroquine and artemisinin, against chloroquineresistance (50005 = FCR-3) and -sensitive (50028 = FCR-8) parasites, we could confirm the biological property of each cell line and the inhibitory activity of each drug (Table 1) . At first, two diastereomers, 10α- (Fig. 3-5 ) and 10β-thiophenyl-dihydroartemisinins (Fig. 3-6) , had a similar inhibition activity with artemisinin. Interestingly, 10α- (Fig. 3-7 ) and 10β-benzenesulfonyl-dihydroartemisinins (Fig. 3-8) showed different inhibitory activity against each cell line according to the change of stereochemistry in the C-10 position of artemisinin. 10β-Diastereomer (Fig. 3-8) was ten times more active than 10α-diastereomer (Fig.  3-7) . In particular, 10β-benzenesulfonyl-dihydroartemisinin ( Fig. 3-8 ) was two times more active than artemisinin and ninety times more than chloroquine. This preliminary screening of each thiophenyland benzenesulfonyl-dihydroartemisinin derivative indicated that 10β-sulfonyl-dihydroartemisinin derivative can be a potentially promising antimalarial drug against chloroquine-resistance parasites. 5 & 6, 10α-and 10β-thiophenyl-dihydroartemisinins; 7 & 8, 10α-and 10β-benzenesulfonyl-dihydroartemisinins. b) IC50 represents the drug concentration producing 50% inhibition of the growth of P. falciparum in drug-free control wells. IC50 values were obtained from plots of the growth-inhibition data.
